NTLA - Wall Street Estimates - Intellia Therapeutics, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 9.5

0.849 %

$ 968 M

Market Cap

-1.74

P/E

Price Target Average

436.84%

Revenue Forecast Estimate

236.32%

EBIT Estimate

--38.87%

Net Income Estimate

33.94%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Intellia Therapeutics, Inc.

Wall Street analysts predict an average 1-year price target for NTLA of $51 , with forecasts ranging from a low of $18 to a high of $80 .

NTLA Lowest Price Target Wall Street Target

18 USD 89.47%

NTLA Average Price Target Wall Street Target

51 USD 436.84%

NTLA Highest Price Target Wall Street Target

80 USD 742.11%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free